Project Grant R03DA065201
Award Date 9/1/26
Completion Date 8/31/28
Dollars Obligated $314K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tempe, AZ 85287, USA
Similar Awards
- The National Institute on Drug Abuse awarded Arizona State University $730,989 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot-test a community-developed parenting intervention program designed to prevent substance use disorder among children with incarcerated parents. The funded work adapts evidence-based parenting program components to address the specific circumstances of caregivers raising children with incarcerated parents (CIP), a...
- The National Institute on Drug Abuse awarded Arizona State University $691,107 on June 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate predictors and outcomes of simultaneous cannabis and alcohol use in daily life. The research will recruit 300 emerging adults who engage in regular simultaneous use and conduct an ecological momentary assessment study with two 28-day data collection bursts at baseline and one-year follow-up. Participants will complete...
- The National Institute on Drug Abuse awarded Arizona State University $193,958 on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a mixed-methods, community-engaged study examining the role of family and household members in reducing opioid overdose deaths. The project investigates household and family-level risk and protective factors associated with opioid overdose mortality, with particular focus on Hispanic populations underrepresented in overdose...
- The National Institute on Drug Abuse awarded Arizona State University $684,625 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the association between environmental heat and drug overdose-related risks among persons who use drugs in Phoenix, Arizona. The research employs a mixed-methods approach integrating big data analytics of Arizona Medicaid and hospital discharge data on drug-related emergency department visits and death certificate data on...
- The National Institute on Drug Abuse awarded the University of California, San Diego $879,000 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and validate a novel episode-based paradigm for studying how family processes drive adolescent substance use. The project will collect real-time, real-world intensive longitudinal data on discrete parent and youth behaviors before and after episodes of substance use from 90 adolescents who use substances....
- The National Institute on Drug Abuse awarded Arizona State University $1,546,664 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct a four-year study characterizing xylazine-adulterated illicitly manufactured fentanyl use and xylazine test strip acceptance in the southwestern United States. The research integrates mixed-methods data collection on xylazine-related knowledge, experiences, and risks with urine toxicology analyses using onsite and...
- The National Institute on Drug Abuse awarded Baylor University $100,228 under the Drug Use and Addiction Research Programs (CFDA 93.279) on January 14, 2027, to improve the measurement and modeling of substance use expectancies and understand risk and protective factors in adolescent development of substance use involving alcohol, cannabis, tobacco, and e-cigarettes. Aim 1 identifies and corrects sources of measurement noninvariance in early social contexts, substance use expectancies, and...
- The National Institute on Drug Abuse awarded New York University $103,607 on August 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct dissertation research on polysubstance use patterns and their associations with methadone maintenance treatment receipt and discontinuation among people who use drugs in New York State. The research uses a mixed-methods approach guided by the Social Ecological Model to identify latent polysubstance use patterns through urine...
- The National Institute on Drug Abuse awarded The McLean Hospital Corporation $981,978 on September 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to validate and extend neurobiological models of resilience and susceptibility to substance use disorders in adolescents exposed to childhood adversity. The project investigates whether specific brain network adaptations distinguish adolescents resilient to substance use despite high adversity burden from those susceptible...
- The National Institute on Drug Abuse awarded Yale University $336,250 on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop a behavioral foundation model that transforms qualitative epidemiological survey responses into quantitative representations of substance use behaviors. The project harmonizes data from the National Epidemiologic Survey on Alcohol and Related Conditions III (NESARC-III), National Survey on Drug Use and Health (NSDUH), and UK Biobank...